13F-HR filed by VHCP Management III, LLC
VHCP Management III, LLC filed this 13F-HR for the quarter ended 2019-06-30, filed 2019-08-13, with 17 holding rows worth $214,180,000.
- Accession
- 0000950123-19-007812
- Filer
- CIK 1738053
- Filed
- 2019-08-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2019
A holdings report, 17 entries on the cover page, a total value of $214,180,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $214,180,000 with VALUE read as thousands by filing date, 13F file number 028-18930. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 2,066,529 | $56,106,000 | thousands by filing date | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 1,611,329 | $41,492,000 | thousands by filing date | |
| RA PHARMACEUTICALS INC | 74933V108 | COM | 670,350 | $20,157,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 637,884 | $14,129,000 | thousands by filing date | |
| ObsEva SA | H5861P103 | COM | 1,159,789 | $13,117,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 1,072,348 | $12,986,000 | thousands by filing date | |
| LA JOLLA PHARMACEUTICAL CO | 503459604 | COM PAR $.0001 2 | 1,251,898 | $11,580,000 | thousands by filing date | |
| TRICIDA INC | 89610F101 | COM | 289,746 | $11,433,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 2,708,207 | $10,264,000 | thousands by filing date | |
| ORCHARD THERAPEUTICS PLC | 68570P101 | ADR | 676,252 | $9,461,000 | thousands by filing date | |
| MARINUS PHARMACEUTICALS INC | 56854Q101 | COM | 1,258,964 | $5,225,000 | thousands by filing date | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 312,320 | $4,229,000 | thousands by filing date | |
| BELLEROPHON THERAPEUTICS INC | 078771102 | COM | 2,417,227 | $1,450,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 422,141 | $870,000 | thousands by filing date | |
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 66,667 | $819,000 | thousands by filing date | |
| GEMPHIRE THERAPEUTICS INC | 36870A108 | COM | 798,066 | $646,000 | thousands by filing date | |
| PROTEOSTASIS THERAPEUTICS IN | 74373B109 | COM | 221,267 | $216,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-19-007812 | this filing | 2019-08-13 | acceptance time not in the bulk data set |